Pharmaceuticals Company Demonstrate Promising Oral Formulation For Alzheimer's Disease

In recent years, the race to find effective treatments for Alzheimer's disease has intensified, driven by the rising prevalence of the condition and the challenges it poses to patients, caregivers, and healthcare systems worldwide. In this context, InMed Pharmaceuticals Inc., a company known for its innovative approaches to drug development, has made considerable strides with its small molecule drug candidate, INM-901. $InMed Pharmaceuticals (INM.US)$